Avantor (AVTR) Non-Current Deferred Tax Liability (2017 - 2026)
Avantor (AVTR) posted quarterly Non-Current Deferred Tax Liability of $539.9 million for Q2 2026, up 0.78% year-over-year from $535.7 million in Q2 2025, and down 1.91% quarter-over-quarter from $550.4 million in Q1 2026.
Avantor (AVTR) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
Avantor's Non-Current Deferred Tax Liability history runs 10 years deep, the most recent figure standing at $539.9 million for Q2 2026.
- In Q2 2026, Non-Current Deferred Tax Liability rose 0.78% year-over-year to $539.9 million; the TTM figure through Jun 2026 stood at $539.9 million (up 0.78% YoY), while the FY2025 annual figure was $557.1 million, down 27.87% from the prior year.
- Non-Current Deferred Tax Liability for Q2 2026 stood at $539.9 million, down from $550.4 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $905.8 million in Q4 2022, with the low at $535.7 million in Q2 2025.
- The 5-year median for Non-Current Deferred Tax Liability is $624.7 million (2023), against an average of $658.5 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability increased 19.83% in 2022, then decreased 27.87% in 2025.
- Avantor's Non-Current Deferred Tax Liability stood at $905.8 million in 2022, then declined by 7.86% to $834.6 million in 2023, then retreated by 7.45% to $772.4 million in 2024, then fell by 27.87% to $557.1 million in 2025, then retreated by 3.09% to $539.9 million in 2026.
- Business Quant data shows AVTR's Non-Current Deferred Tax Liability at $539.9 million in Q2 2026, $550.4 million in Q1 2026, and $557.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Avantor | 9.76 Bn | 9.45 Bn | 537.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 539.90 Mn |
| Jun 30, 2026 | 539.90 Mn |
| Mar 31, 2026 | 550.40 Mn |
| Mar 31, 2026 | 550.40 Mn |
| Dec 31, 2025 | 557.10 Mn |
| Dec 31, 2025 | 557.10 Mn |
| Sep 30, 2025 | 548.50 Mn |
| Sep 30, 2025 | 548.50 Mn |
| Jun 30, 2025 | 535.70 Mn |
| Jun 30, 2025 | 535.70 Mn |
| Mar 31, 2025 | 550.00 Mn |
| Mar 31, 2025 | 550.00 Mn |
| Dec 31, 2024 | 772.40 Mn |
| Dec 31, 2024 | 772.40 Mn |
| Sep 30, 2024 | 547.30 Mn |
| Sep 30, 2024 | 547.30 Mn |
| Jun 30, 2024 | 575.40 Mn |
| Jun 30, 2024 | 575.40 Mn |
| Mar 31, 2024 | 600.60 Mn |
| Mar 31, 2024 | 600.60 Mn |